CRWV insider filing: 375,000 shares via Morgan Stanley, 10b5-1 sale history

Rhea-AI Filing Summary

Form 144 Notice for CoreWeave, Inc. (CRWV) shows a proposed sale of 375,000 common shares through Morgan Stanley Smith Barney with an aggregate market value of $35,081,250, scheduled approximately for 09/09/2025 on NASDAQ. The shares were acquired as founders shares on 11/13/2017. The filing also lists recent Rule 10b5-1 sales by related parties: multiple executions on 08/19, 08/26 and 09/02/2025 totaling several blocks of 250,000 and 375,000 shares with gross proceeds reported for each trade. The filer attests no undisclosed material nonpublic information and follows required signatures and disclosures.

Insights

Securities Analyst

TL;DR: Routine insider sale filed under Rule 144 and executed via 10b5-1 plans; sizes are small relative to the outstanding share count.

The filing documents a proposed sale of 375,000 shares valued at $35.08 million and shows multiple recent 10b5-1 transactions for the same accounts. Compared with the reported 370,470,348 shares outstanding, the single proposed block represents about 0.10% of the float, indicating limited dilution or market-impact risk from this filing alone. The shares were originally acquired as founders shares in 2017, and the use of a major brokerage suggests standard market execution procedures.

Compliance/Risk Analyst

TL;DR: Filing appears procedurally complete and includes 10b5-1 sales history and the required attestation against undisclosed material information.

The notice lists the broker, acquisition history, and recent sales under 10b5-1 plans, which supports compliance with trading-plan safe harbor practices. The filer’s attestation that they lack undisclosed material information is included. No regulatory flags or execution anomalies are evident from the document text provided.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	375000	35081250.00	370470348	09/09/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/13/2017	Founders Shares	Issuer			375000	11/13/2017	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/02/2025	250000	23292325.00
10b5-1 Sales for BRANNIN J. MCBEE 2022 IRR TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/02/2025	375000	34938487.50
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/26/2025	250000	22996925.00
10b5-1 Sales for BRANNIN J. MCBEE 2022 IRR TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/26/2025	375000	34495387.50
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/19/2025	250000	22926475.00
10b5-1 Sales for BRANNIN J. MCBEE 2022 IRR TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/19/2025	375000	34389712.50

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does the Form 144 for CRWV report?

The filing reports a proposed sale of 375,000 common shares of CoreWeave (CRWV).

When is the approximate sale date listed in the Form 144?

The approximate sale date is listed as 09/09/2025.

What is the aggregate market value of the securities to be sold?

The aggregate market value reported is $35,081,250.00.

Who is the broker handling the proposed sale?

The broker named is Morgan Stanley Smith Barney LLC, Executive Financial Services in New York.

Were there recent related sales disclosed?

Yes; the filing lists multiple 10b5-1 sales on 08/19/2025, 08/26/2025 and 09/02/2025 involving 250,000 and 375,000 share blocks with gross proceeds noted for each.

When were the shares being sold originally acquired?

The shares were acquired as founders shares on 11/13/2017.